|
|
|
|
|
By Marina A. Dobrovolskaia, Frederick National Laboratory for Cancer Research | This article highlights government-funded resources available to de-risk nanomedicines, reviews principles of immunotoxicity testing, and discusses emerging methodologies. | |
|
|
|
|
| Evaluating Membrane Filtration For High Microbial Recovery | Application Note | By Maria Martinez Lobete, Cytiva | Compare membrane materials and pore sizes to assess their impact on flow rate and microbial recovery. See how fast filtration and ≥90% organism recovery offer guidance for selecting reliable membranes. |
|
|
| Manifolding For Scale-Up, Safety, And Speed | Article | By Chris Hofmann, Charter Medical | The use of manifolds to fill bags for bioprocessing or advanced therapies contributes to time savings, improved process quality, and optimal use of cleanroom and personnel resources. |
|
|
|
|
|
| Optimizing And Scaling Lentiviral Vector Production | Application Note | MilliporeSigma | Upstream and downstream vector production benefits from systematic process refining. See how design of experiments methodology elevates output across all stages of manufacturing. |
|
|
|
|
|
|
|
| Webinar: Evolving Lentiviral Vector Manufacturing with Stable Production | As in vivo lentiviral programs expand, manufacturers need scalable, reliable production platforms that deliver consistent quality. Join Asimov's Sybil Danby and Adam Carcella to explore next-generation LV manufacturing strategies, including producer and packaging cell lines, and learn how synthetic biology and computational modeling are improving titer, reducing variability, and accelerating development for both ex vivo and in vivo therapies. Click here to learn more. |
|
|
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|